SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
TC Biopharm (Holdings) Plc (TCBP) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 40/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — TCBP
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-9.56
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-138.00 |
$3.43M |
$-6.07M |
-177.1% |
| 2020 |
$-124.00 |
$1.98M |
$-5.46M |
-275.8% |
| 2021 |
$-82,488.00 |
$1.98M |
$-13.58M |
-686.1% |
| 2022 |
$-19.12 |
$3.84M |
$-1.31M |
-34.2% |
| 2023 |
$-9.56 |
$0.00 |
$-5.91M |
- |
